These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2872721)

  • 1. Minimization and overreaction to tardive dyskinesia.
    Munetz MR; Schulz SC
    Schizophr Bull; 1986; 12(2):168-72. PubMed ID: 2872721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Legal aspects of tardive dyskinesia.
    Davis JM; Comaty J
    Encephale; 1988 Sep; 14 Spec No():257-61. PubMed ID: 2905653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tardive dyskinesia: legal and preventive aspects.
    Shriqui CL; Bradwejn J; Jones BD
    Can J Psychiatry; 1990 Oct; 35(7):576-80. PubMed ID: 1980092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tardive dyskinesia: a current review].
    Shriqui CL
    Can J Psychiatry; 1988 Oct; 33(7):637-44. PubMed ID: 2904299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing neuroleptic-induced tardive dyskinesia in adults and children.
    Lam RW; Jeste SD; Jeste DV
    Encephale; 1988 Sep; 14 Spec No():251-5. PubMed ID: 2905652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    McGrath JJ; Soares KV
    Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is tardive dyskinesia a unique disorder?
    Marsden CD
    Psychopharmacology Suppl; 1985; 2():64-71. PubMed ID: 2860661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatrists' attitudes about and informed consent practices for antipsychotics and tardive dyskinesia.
    Schachter DC; Kleinman I
    Psychiatr Serv; 2004 Jun; 55(6):714-7. PubMed ID: 15175474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive dyskinesia and informed consent: myths and realities.
    Munetz MR; Roth LH; Cornes CL
    Bull Am Acad Psychiatry Law; 1982; 10(2):77-88. PubMed ID: 6129012
    [No Abstract]   [Full Text] [Related]  

  • 11. Tardive dyskinesia in schizophrenics under 60 years of age.
    Kolakowska T; Williams AO; Ardern M; Reveley MA
    Biol Psychiatry; 1986 Feb; 21(2):161-9. PubMed ID: 2868762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological determinants and risk factors for tardive dyskinesia in schizophrenia.
    Sandyk R
    Int J Neurosci; 1993; 69(1-4):35-51. PubMed ID: 7916008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III.
    van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS
    Am J Psychiatry; 1998 Apr; 155(4):565-7. PubMed ID: 9546009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current status of tardive dyskinesia.
    Sachdev PS
    Aust N Z J Psychiatry; 2000 Jun; 34(3):355-69. PubMed ID: 10881961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and management of tardive dyskinesia.
    Jeste DV; Wyatt RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tardive dyskinesia: prevalence, incidence, and risk factors.
    Kane JM; Woerner M; Lieberman J
    Psychopharmacology Suppl; 1985; 2():72-8. PubMed ID: 2860662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Informed consent and tardive dyskinesia.
    Kleinman I; Schachter D; Koritar E
    Am J Psychiatry; 1989 Jul; 146(7):902-4. PubMed ID: 2568093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic side effects: acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE; Keepers GA
    Psychopharmacol Ser; 1988; 5():74-93. PubMed ID: 2901085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of late-life schizophrenia with neuroleptics.
    Jeste DV; Lacro JP; Gilbert PL; Kline J; Kline N
    Schizophr Bull; 1993; 19(4):817-30. PubMed ID: 7905663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depot neuroleptics: side effects and safety.
    Marder SR
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):24S-29S. PubMed ID: 2870089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.